Background: The European Society of Urogenital Radiology (ESUR) propose measurements of serum creatinine levels in patients undergoing contrast-enhanced studies with a high probability of impaired renal function and therefore with a higher risk of CIN and NSF.
Purpose: To determine whether the recommended questionnaire is able to select these patients.
Material And Methods: Over a time period of 10 months the questionnaire was conducted in 1389 patients (725 women, 654 men) before contrast administration for computed tomography (CT) or magnetic resonance imaging (MRI) examination. Serum creatinine (SCr) measurements and calculation of estimated glomerular filtration rate (eGFR) values were performed when one or more answers were positive. Eighty-one patients were excluded due to incomplete data. Statistical evaluation of the questionnaire was done retrospectively.
Results: Four hundred and ninety-nine patients (38%) gave one or more positive answers to the questionnaire. Of these, 71 (14%) had an eGFR <60 mL/min/1.73 m(2), 31 (6%) had an eGFR <45 mL/min/1.73 m(2), and five (1%) had an eGFR <30 mL/min/1.73 m(2). Only the question concerning previous renal disease showed a significant correlation to an eGFR <60 mL/min/1.73 m(2) (P < 0.05) and <45 mL/min/1.73 m(2). Slight correlations with some other risk factors (renal disease, family history of renal disease, arterial hypertension with medication, analgetic medication with nephrotoxic drugs) were found for either a threshold of 60 or 45 mL/min/1.73 m(2). In addition, there was a positive correlation with patient age.
Conclusion: We propose to reduce the questionnaire to a smaller number of risk factors and consider a point-of-care (POC) SCr measurement for all patients aged >70 years without a recent eGFR value while referred for CT. For MRI a SCr measurement is not mandatory while using medium and lowest risk contrast agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0284185114533244 | DOI Listing |
Curr Med Chem
January 2025
Department of Pediatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Background: Hyperuricemia (HUA) is a condition characterized by excessive uric acid production and/or inadequate uric acid excretion due to abnormal purine metabolism in the human body. Uric acid deposits resulting from HUA can lead to complications such as renal damage. Currently, drugs used to treat HUA lack specificity and often come with specific toxic side effects.
View Article and Find Full Text PDFJ Cancer
January 2025
Department of Respiratory and Critical Care Medicine, The Second People's Hospital of Jingdezhen, Jingdezhen, China.
The prevailing belief is that third-generation tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor (EGFR) (TGET) outperform first-generation EGFR-TKIs (FGET) in managing advanced-stage EGFR-mutated non-small cell lung cancer (NSCLC). However, this standpoint lacks substantiation in evidence-based medicine. Therefore, this meta-analysis was conducted to compare the efficacy and adverse effects (AEs) of these two categories.
View Article and Find Full Text PDFJ Transplant
December 2024
Medical College of Georgia, Augusta University Hospital and Medical Center, 1120 15th Street, Augusta AD 3401, Georgia.
Donor-derived cell-free DNA (dd-cfDNA) in the peripheral blood of allograft recipients has shown to early identify allograft injury. In this study, we assessed the factors that influence the amount of circulating dd-cfDNA during the first month postkidney transplant as well as its longitudinal trend. A consecutive series of 98 adult kidney transplant recipients at a single center between July 2018 and January 2020 were included in this study.
View Article and Find Full Text PDFZhonghua Wei Zhong Bing Ji Jiu Yi Xue
December 2024
Department of Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, China. Corresponding author: Wang Xuebin, Email:
Objective: To observe the clinical efficacy of vitamin B1 in patients with ICU-acquired weakness (ICU-AW).
Methods: A retrospective analysis was conducted to select ICU-AW patients treated with vitamin B1 in the intensive care unit (ICU) of Shanghai East Hospital, Tongji University from July 2022 to December 2023. Propensity score matching was used to match the control group and observation group at a 1 : 1 ratio, considering differences in patient age, gender, and acute physiology and chronic health evaluation II (APACHE II).
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
December 2024
Department of Emergency, Kweichow Moutai Hospital, Renhuai 564500, Guizhou, China. Corresponding author: Ou Renyang, Email:
Objective: To investigate the protective effect and mechanism of tumor necrosis factor receptor-associated factor 6 (TRAF6) inhibitor C25-140 on acute kidney injury (AKI) induced by acute diquat (DQ) poisoning in mice.
Methods: A total of 80 SPF grade healthy male C57BL/6 mice were randomly divided into the normal control group, DQ model group, C25-140 intervention group, and C25-140 control group, with 20 mice in each group. The DQ poisoning mouse model was established by using one-time intraperitoneal injection of 1 mL of 40 mg/kg DQ solution.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!